Genomic Valley Biotech shareholders and shareholding pattern
BSE: 539206Pharmaceuticals & BiotechnologySmall Cap
Last close ₹37.71up ₹1.79 (4.98%)
Share price at the BSE close on 23 Oct 2026. Previous close ₹35.92.
52-week range of traded prices to 23 Oct 2026
₹20.10Low, 29 Jan 2026₹38.20High, 6 Nov 2025
- Under BSE's graded surveillance, stage 0, on the list for 22 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Next results date: the board meets on 30 Oct 2026 to consider: quarterly results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹12 Cr4,774th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 15 Aug 2026
- 567.4
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 30 May 2026
- 2.9
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 15 Aug 2026
- 0.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 15 Aug 2026
- 0.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 30 May 2026
- 0.00
- Volume, BSEVolume. Shares traded on the last trading day.
- 2,994
Who owns Genomic Valley Biotech, filing by filing
Per cent of the company's shares. The last ten years of filings, from Dec 2016; the latest is the filing for Sep 2026.
Sep 2026 filing
- Promoters46.06%
- Individuals and others53.94%
Shareholding pattern, per cent, from Sep 2022
- Promoters
- Individuals and others
| Per cent | Dec 2016Filed 4 Jan | Mar 2017Filed 6 Apr | Jun 2017Filed 7 Jul | Sep 2017Filed 10 Oct | Dec 2017Filed 8 Jan | Mar 2018Filed 19 Apr | Jun 2018Filed 10 Jul | Sep 2018Filed 10 Oct | Dec 2018Filed 19 Jan | Mar 2019Filed 19 Apr | Jun 2019Filed 7 Jul | Sep 2019Filed 10 Oct | Dec 2019Filed 7 Jan | Mar 2020Filed 22 Apr | Jun 2020Filed 20 Jul | Sep 2020Filed 14 Oct | Dec 2020Filed 8 Jan | Mar 2021Filed 21 Apr | Jun 2021Filed 7 Jul | Sep 2021Filed 21 Oct | Dec 2021Filed 12 Jan | Mar 2022Filed 12 Apr | Jun 2022Filed 8 Jul | Sep 2022Filed 18 Oct | Dec 2022Filed 12 Jan | Mar 2023Filed 19 Apr | Jun 2023Filed 19 Jul | Sep 2023Filed 10 Oct | Dec 2023Filed 18 Jan | Mar 2024Filed 21 Apr | Jun 2024Filed 17 Jul | Sep 2024Filed 16 Oct | Dec 2024Filed 15 Jan | Mar 2025Filed 8 May | Jun 2025Filed 17 Jul | Sep 2025Filed 9 Oct | Dec 2025Filed 8 Jan | Mar 2026Filed 1 May | Jun 2026Filed 14 Jul | Sep 2026Filed 12 Oct |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 64.22% | 64.22% | 64.22% | 64.22% | 67.67% | 67.85% | 67.85% | 67.85% | 67.85% | 24.85% | 67.85% | 67.85% | 67.85% | 67.85% | 67.85% | 67.85% | 67.85% | 67.85% | 67.85% | 67.85% | 67.85% | 67.85% | 67.85% | 67.85% | 67.85% | 67.18% | 67.18% | 66.32% | 65.04% | 64.20% | 64.14% | 54.67% | 46.83% | 46.78% | 46.72% | 46.72% | 46.06% | 46.06% | 46.06% | 46.06% | |
| Indian promoters | 64.22% | 64.22% | 64.22% | 64.22% | 67.67% | 67.85% | 67.85% | 67.85% | 67.85% | 24.85% | 67.85% | 67.85% | 67.85% | 67.85% | 67.85% | 67.85% | 67.85% | 67.85% | 67.85% | 67.85% | 67.85% | 67.85% | 67.85% | 67.85% | 67.85% | 67.18% | 67.18% | 66.32% | 65.04% | 64.20% | 64.14% | 54.67% | 46.83% | 46.78% | 46.72% | 46.72% | 46.06% | 46.06% | 46.06% | 46.06% |
| Public. Every shareholder outside the promoter group, the employee trusts and the shares held against depositary receipts, as the filing totals them. | 35.78% | 35.78% | 35.78% | 35.78% | 32.33% | 32.15% | 32.15% | 32.15% | 32.15% | 75.15% | 32.15% | 32.15% | 32.15% | 32.15% | 32.15% | 32.15% | 32.15% | 32.15% | 32.15% | 32.15% | 32.15% | 32.15% | 32.15% | 32.15% | 32.15% | 32.82% | 32.82% | 33.68% | 34.96% | 35.80% | 35.86% | 45.33% | 53.17% | 53.22% | 53.28% | 53.28% | 53.94% | 53.94% | 53.94% | 53.94% |
| Promoter shares pledgedShare of the promoters' own shares | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 63.38% | 63.38% | 63.38% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Shares in issue | 30,54,500 | 30,54,500 | 30,54,500 | 30,54,500 | 30,54,500 | 30,54,500 | 30,54,500 | 30,54,500 | 30,54,500 | 30,54,500 | 30,54,500 | 30,54,500 | 30,54,500 | 30,54,500 | 30,54,500 | 30,54,500 | 30,54,500 | 30,54,500 | 30,54,500 | 30,54,500 | 30,54,500 | 30,54,500 | 30,54,500 | 30,54,500 | 30,54,500 | 30,54,500 | 30,54,500 | 30,54,500 | 30,54,500 | 30,54,500 | 30,54,500 | 30,54,500 | 30,54,500 | 30,54,500 | 30,54,500 | 30,54,500 | 30,54,500 | 30,54,500 | 30,54,500 | 30,54,500 |
Filings before Sep 2022 are on an older form, which did not split institutions into foreign and Indian and grouped some holders differently, so those columns show only the lines both forms state alike. Pledged is the share of the promoters' own shares given to lenders as security. A dash is a line the filing did not state. “Under 0.01%” is a holding of shares too small to show at two decimals.
Genomic Valley Biotech promoters
Promoters are the founders, families and companies that control the company, as its filings name them. Every member of the promoter group holding shares in the filing for Sep 2026; the largest is Yogesh Agrawal, 46.06%. The filing names 2 more members with no shares.Promoter buying and selling
| Holder | ||
|---|---|---|
| Yogesh AgrawalIndividuals and Hindu undivided families | 46.06% | 14,07,000 |
No promoter shares are reported as pledged.
Largest public holders of Genomic Valley Biotech, filing by filing
Per cent, on the same shares as the split above.
| Holder | Dec 2016Filed 4 Jan | Mar 2017Filed 6 Apr | Jun 2017Filed 7 Jul | Sep 2017Filed 10 Oct | Dec 2017Filed 8 Jan | Mar 2018Filed 19 Apr | Jun 2018Filed 10 Jul | Sep 2018Filed 10 Oct | Dec 2018Filed 19 Jan | Mar 2019Filed 19 Apr | Jun 2019Filed 7 Jul | Sep 2019Filed 10 Oct | Dec 2019Filed 7 Jan | Mar 2020Filed 22 Apr | Jun 2020Filed 20 Jul | Sep 2020Filed 14 Oct | Dec 2020Filed 8 Jan | Mar 2021Filed 21 Apr | Jun 2021Filed 7 Jul | Sep 2021Filed 21 Oct | Dec 2021Filed 12 Jan | Mar 2022Filed 12 Apr | Jun 2022Filed 8 Jul | Sep 2022Filed 18 Oct | Dec 2022Filed 12 Jan | Mar 2023Filed 19 Apr | Jun 2023Filed 19 Jul | Sep 2023Filed 10 Oct | Dec 2023Filed 18 Jan | Mar 2024Filed 21 Apr | Jun 2024Filed 17 Jul | Sep 2024Filed 16 Oct | Dec 2024Filed 15 Jan | Mar 2025Filed 8 May | Jun 2025Filed 17 Jul | Sep 2025Filed 9 Oct | Dec 2025Filed 8 Jan | Mar 2026Filed 1 May | Jun 2026Filed 14 Jul | Sep 2026Filed 12 Oct |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DEEPTI AGGARWALResident individuals, over ₹2 lakh at face value | 1.83% | 1.83% | 1.83% | 1.83% | 11.00% | 11.00% | 11.00% | 11.00% | 11.00% | 11.00% | 11.00% | 11.00% | 11.00% | 11.00% | 11.00% | 11.00% | 11.00% | 11.00% | 11.00% | 11.00% | 11.00% | 11.00% | 11.00% | 11.00% | 11.00% | 11.00% | 11.00% | 11.00% | 11.00% | 11.00% | 11.00% | 11.00% | 11.00% | 11.00% | 11.00% | 11.00% | 11.00% | 11.00% | 11.00% | 11.00% |
| AMAR AGGARWALResident individuals, over ₹2 lakh at face value | 1.83% | 1.83% | 1.83% | 1.83% | 9.05% | 9.05% | 9.05% | 9.05% | 9.05% | 9.05% | 9.05% | 9.05% | 9.05% | 9.05% | 9.05% | 9.05% | 9.05% | 9.05% | 9.05% | 9.05% | 9.05% | 9.05% | 9.05% | 9.05% | 9.05% | 9.05% | 9.05% | 9.05% | 9.05% | 9.05% | 9.05% | 9.05% | 9.05% | 9.05% | 9.05% | 9.05% | 9.05% | 9.05% | 9.05% | 9.05% |
| VIKRAM ASHOKKUMAR JAINResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 5.50% | 5.50% | 5.50% | 5.50% | 5.50% | 5.50% | 5.50% | 5.50% |
| WASP TRADMART PRIVATE LIMITEDCompanies | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.25% | 1.19% | 1.06% |
| Purushothaman ShajiResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 2.53% | 2.69% | 3.72% | 2.64% | – | – | – | – |
| Harish Chandra SharmaResident individuals, over ₹2 lakh at face value | – | – | – | – | 2.91% | 3.22% | 3.22% | 11.42% | 11.42% | 11.42% | 11.42% | 11.42% | 11.42% | 11.42% | 11.42% | 11.41% | 11.41% | 11.41% | 11.41% | 11.41% | 11.41% | 11.41% | 11.41% | 11.41% | 11.41% | 11.41% | 11.35% | 8.73% | 4.81% | 4.81% | 4.81% | 2.87% | – | – | – | – | – | – | – | – |
| Sunglow Fininvest Pvt LtdOther non-institutions | – | – | – | – | – | – | – | – | – | 43.00% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| GEEP INDUSTRIAL SYNDICATE LIMITEDOther non-institutions | 8.18% | 8.18% | 8.18% | 8.18% | 8.18% | 8.18% | 8.18% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| ANJU BANSALResident individuals, over ₹2 lakh at face value | 1.83% | 1.83% | 1.83% | 1.83% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| DR. VIJAYSHRIResident individuals, over ₹2 lakh at face value | 1.83% | 1.83% | 1.83% | 1.83% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| KRISHNA KUMAR BANSALResident individuals, over ₹2 lakh at face value | 1.83% | 1.83% | 1.83% | 1.83% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| LALA RAMResident individuals, over ₹2 lakh at face value | 1.83% | 1.83% | 1.83% | 1.83% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| RAMESH KUMAR BANSALResident individuals, over ₹2 lakh at face value | 1.83% | 1.83% | 1.83% | 1.83% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| SAROJ BANSALResident individuals, over ₹2 lakh at face value | 1.83% | 1.83% | 1.83% | 1.83% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| DR. JYOTI AGGARWALResident individuals, over ₹2 lakh at face value | 1.80% | 1.80% | 1.80% | 1.80% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| KOUTILYA BANSALResident individuals, over ₹2 lakh at face value | 1.80% | 1.80% | 1.80% | 1.80% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| SHARBATI DEVIResident individuals, over ₹2 lakh at face value | 1.78% | 1.78% | 1.78% | 1.78% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
A filing names every holder above one per cent, in the company's own words: an insurer's holding can carry one of its funds' names. A dash is a filing that did not name the holder, which includes holding under one per cent.